Related Experiment Video
Updated: Jun 25, 2025

An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
Medicare Should Cover Weight Loss Drugs as Long as the Prices are Affordable
Catherine S Hwang1, Aaron S Kesselheim1, Benjamin N Rome1
1DIVISION OF PHARMACOEPIDEMIOLOGY AND PHARMACOECONOMICS, DEPARTMENT OF MEDICINE, BRIGHAM AND WOMEN'S HOSPITAL AND HARVARD MEDICAL SCHOOL, BOSTON, MA.
Abstract:
Glucagon-like peptide-1 receptor agonists are effective for treating obesity, but the high cost of these medications endangers the financial viability of our health care system. To ensure that these drugs are available to Medicare beneficiaries, pharmaceutical manufacturers must lower their prices.
More Related Videos
Related Concept Videos
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Antidepressant Drugs: MAOIs and Other Agents
Oral Hypoglycemic Agents: Biguanides and Glitazones
Obesity
Drug Therapy
Antianxiety Medications

